drugset / Trial / NCT01196767

Ropivacaine Though Laterosternal Catheters After Cardiac Surgery

NCT01196767 ↗

Phase 4 Completed 40 enrolled University Hospital, Clermont-Ferrand
RandomizedParallel-groupDouble-blind

Summary

This is a prospective double-blinded and randomised study involving patients undergoing cardiac surgery with median sternotomy, the effects on postoperative analgesia of a 48-hr continuous infusion of ropivacaine 2 mg.mL-1, at the rate of 4 mL.hr-1 through two catheters inserted at the lateral edges of the sternum will be studied, versus a control group in which normal saline will be infused in the same conditions.

Timeline

Start
2010-07
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 2 mg/ml Subcutaneous

Indications

No indication recorded.